| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.BEHA.2010.09.001 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1521692610000629?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S1521692610000629?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 21112040 |
| P50 | author | Brunangelo Falini | Q30119395 |
| Maria Paola Martelli | Q88187052 | ||
| Christian Thiede | Q42323747 | ||
| Stefano A Pileri | Q86426885 | ||
| P2093 | author name string | Enrico Tiacci | |
| Stefano Ascani | |||
| P2860 | cites work | ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK) | Q24336482 |
| EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues | Q24645724 | ||
| TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors | Q24669567 | ||
| Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype | Q27824827 | ||
| Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer | Q27851410 | ||
| Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth | Q28216536 | ||
| Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma | Q28250347 | ||
| Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3 | Q28253494 | ||
| Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias | Q28301353 | ||
| Role of nucleophosmin in embryonic development and tumorigenesis | Q28591282 | ||
| Major nucleolar proteins shuttle between nucleus and cytoplasm | Q29620425 | ||
| Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification | Q33254865 | ||
| ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy | Q33380513 | ||
| Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes | Q33699243 | ||
| Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms | Q34099059 | ||
| Anaplastic large cell lymphoma: pathological, molecular and clinical features. | Q34374218 | ||
| Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry | Q34487204 | ||
| Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet | Q34597535 | ||
| "In situ-like" mantle cell lymphoma: a report of two cases | Q35770272 | ||
| Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling | Q35848185 | ||
| Nucleophosmin and cancer | Q36516405 | ||
| Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features | Q36606696 | ||
| ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature | Q36727991 | ||
| Improving the Treatment Outcome of Acute Promyelocytic Leukemia in Developing Countries through International Cooperative Network. Report On the International Consortium On Acute Promyelocytic Leukemia Study Group. | Q127022098 | ||
| The anaplastic lymphoma kinase in the pathogenesis of cancer | Q37039605 | ||
| Advances in the understanding of mantle cell lymphoma | Q37137955 | ||
| SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. | Q37406791 | ||
| Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt's lymphoma | Q37406794 | ||
| Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications. | Q37514846 | ||
| How I treat mantle cell lymphoma. | Q37531574 | ||
| Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives | Q37601266 | ||
| Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. | Q40321232 | ||
| Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin | Q40389129 | ||
| An immunofluorescent assay for acute promyelocytic leukemia cells | Q41043170 | ||
| Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type | Q41953773 | ||
| A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF. | Q42806442 | ||
| Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants | Q42826742 | ||
| Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help. | Q42832529 | ||
| ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. | Q42850888 | ||
| Anaplastic large cell lymphoma: changes in the World Health Organization classification and perspectives for targeted therapy. | Q43103153 | ||
| ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases | Q44451877 | ||
| Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody | Q44913301 | ||
| Immunofluorescent analysis with the anti-PML monoclonal antibody PG-M3 for rapid and accurate genetic diagnosis of acute promyelocytic leukemia | Q44996369 | ||
| Rapid flow cytometric detection of aberrant cytoplasmic localization of nucleophosmin (NPMc) indicating mutant NPM1 gene in acute myeloid leukemia. | Q46156916 | ||
| ALK-positive anaplastic large cell lymphoma mimicking nodular sclerosis Hodgkin's lymphoma: report of 10 cases. | Q51822094 | ||
| The rapid diagnosis of acute promyelocytic leukaemia using PML (5E10) monoclonal antibody. | Q52867615 | ||
| Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. | Q53561028 | ||
| SP4, a novel anti-cyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14)(q13;q32) translocation. | Q53649725 | ||
| In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. | Q54398146 | ||
| The nucleolus | Q57166314 | ||
| The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma | Q57279573 | ||
| Rapid Diagnosis of Acute Promyelocytic Leukemia by Analyzing the Immunocytochemical Pattern of the PML Protein With the Monoclonal Antibody PG-M3 | Q57279652 | ||
| CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report | Q57647013 | ||
| Aberrant Bcl6 Protein Expression in Mantle Cell Lymphoma | Q58010967 | ||
| Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia | Q58882378 | ||
| A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia | Q60171386 | ||
| Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas | Q61637145 | ||
| In-situ mantle cell lymphoma-a report of two cases | Q63633967 | ||
| Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance | Q72400586 | ||
| Lymphomas expressing ALK fusion protein(s) other than NPM-ALK | Q73160429 | ||
| A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus | Q80880100 | ||
| Mantle cell lymphoma with aberrant expression of CD10 | Q81384010 | ||
| Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): a comparison with NPMc+ AML | Q81600809 | ||
| A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias | Q84386374 | ||
| Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms | Q84626091 | ||
| Immunophenotypic variations in mantle cell lymphoma | Q84761573 | ||
| Mantle cell lymphoma | Q84826641 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunohistochemistry | Q899285 |
| P304 | page(s) | 417-431 | |
| P577 | publication date | 2010-09-01 | |
| 2010-10-29 | |||
| P1433 | published in | Best Practice and Research: Clinical Haematology | Q15755888 |
| P1476 | title | Immunohistochemical surrogates for genetic alterations of CCDN1, PML, ALK, and NPM1 genes in lymphomas and acute myeloid leukemia | |
| Immunohistochemical Surrogates for Genetic Alterations of CCDN1, PML, ALK, and NPM1 Genes in Lymphomas and Acute Myeloid Leukemia | |||
| P478 | volume | 23 |
| Q84578015 | ERG gene rearrangement status in prostate cancer detected by immunohistochemistry | cites work | P2860 |
Search more.